Yield10 Bioscience, Inc. (YTEN) Tops Q2 EPS by 38c

Go back to Yield10 Bioscience, Inc. (YTEN) Tops Q2 EPS by 38c

Yield10 Bioscience Announces Second Quarter 2020 Financial Results

August 11, 2020 4:05 PM EDT

WOBURN, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June 30, 2020.

"The Yield10 team has made good progress executing on our strategic plans for 2020 and beyond," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10 Bioscience. "Our field tests in the U.S. and Canada are progressing on track and will provide us with agronomic and/or performance data proof points as well as seed for larger trials planned in... More